Zoladex Continuity Program – UPDATE 16 July

So Brave received the following updated advice from AstraZeneca this afternoon:

ONGOING ACCESS TO ZOLADEX® (goserelin) MONTHLY (3.6mg) IMPLANT IN AUSTRALIA

PBS News: Update on access to goserelin 3.6 mg implant (Zoladex Implant™)